Evercore ISI lowered the firm’s price target on Icon to $350 from $360 and keeps an Outperform rating on the shares. The firm is adjusting estimates and making additions to Evercore’s “Tactical Outperform” and “Tactical Underperform” lists ahead of Q3 earnings from the Healthcare Technology and Distribution group.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICLR:
Questions or Comments about the article? Write to editor@tipranks.com